Abstract
Objective
The aim of this study was to evaluate the efficacy and safety of endovascular treatment of hemoptysis caused by primary lung cancer.
Methods
We conducted a single-center retrospective study (2005–2021), including patients who underwent thoracic embolization for life-threatening hemoptysis complication of lung cancer. Exclusion criteria were hemoptysis caused by a benign lung tumor or by a lung metastasis of a primary non-lung tumor. Depending on the origin of the bleeding, determined by CT-angiography, systemic arteries were treated with microspheres or coils, and pulmonary arteries with coils, plugs or covered stents. Outcomes were assessed from patients' medical records in April 2022. Primary endpoints were clinical success at one month and at one year. Secondary endpoints were incidence of complications, 1 year overall survival, and relative risk of recurrence of hemoptysis. Survival was compared with a log-rank test.
Results
Sixty-two patients underwent 68 systemic artery embolizations and 14 pulmonary artery procedures. Clinical success defined as cessation of hemoptysis without any recurrence was 81% at one month and 74% at one year. Three major complications occurred: spinal cord ischemia, stroke, and acute pancreatitis. 5% of patient died from hemoptysis. One-year overall survival was 29% and was significantly higher in patients without hemoptysis recurrence when compared to patients with recurring hemoptysis (p = 0.021). In univariate analysis, recurrence of hemoptysis at one year was associated with massive hemoptysis (RR = 2.50; p = 0.044) and with tumor cavitation (RR = 2.51; p = 0.033).
Conclusion
Endovascular treatment for primary lung cancer-related hemoptysis is effective but not uneventful.
Similar content being viewed by others
Abbreviations
- BAE:
-
Bronchial artery embolization
- BMI:
-
Body-mass index
- CIRSE:
-
Cardiovascular and Interventional Radiological Society of Europe
- COPD:
-
Chronic obstructive pulmonary disease
- CT:
-
Computed tomography
- IASLC:
-
International Association for the Study of Lung Cancer
- ICAE:
-
Intercostal artery embolization
- IMAE:
-
Internal mammary artery embolization
- NSCLC:
-
Non-small cell lung cancer
- PAE:
-
Pulmonary artery embolization
- PE:
-
Pulmonary embolism
- SCLC:
-
Small cell lung cancer
- WHO:
-
World Health Organization
References
Walter FM, Rubin G, Bankhead C, Morris HC, Hall N, Mills K, et al. Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study. Br J Cancer. 2015;112(Suppl 1):S6-13. https://doi.org/10.1038/bjc.2015.30.
Gershman E, Guthrie R, Swiatek K, Shojaee S. Management of hemoptysis in patients with lung cancer. Ann Transl Med. 2019;7:358. https://doi.org/10.21037/atm.2019.04.91.
Charya AV, Holden VK, Pickering EM. Management of life-threatening hemoptysis in the ICU. J Thorac Dis. 2021;13:5139–58. https://doi.org/10.21037/jtd-19-3991.
Almeida J, Leal C, Figueiredo L. Evaluation of the bronchial arteries: normal findings, hypertrophy and embolization in patients with hemoptysis. Insights Imaging. 2020;11:70. https://doi.org/10.1186/s13244-020-00877-4.
Chun J-Y, Morgan R, Belli A-M. Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization. Cardiovasc Interv Radiol. 2010;33:240–50. https://doi.org/10.1007/s00270-009-9788-z.
Syha R, Benz T, Hetzel J, Spengler W, Kohlhäufl MJ, Gatidis S, et al. Bronchial artery embolization in hemoptysis: 10-year survival and recurrence-free survival in benign and malignant etiologies: a retrospective study. Rofo. 2016;188:1061–6. https://doi.org/10.1055/s-0042-112227.
Fartoukh M, Khoshnood B, Parrot A, Khalil A, Carette M-F, Stoclin A, et al. Early prediction of in-hospital mortality of patients with hemoptysis: an approach to defining severe hemoptysis. Respiration. 2012;83:106–14. https://doi.org/10.1159/000331501.
Xu S, Guan L-J, Shi B-Q, Tan Y-S, Zhang X-J. Recurrent hemoptysis after bronchial artery embolization: prediction using a nomogram and artificial neural network model. AJR Am J Roentgenol. 2020;215:1490–8. https://doi.org/10.2214/AJR.20.22775.
Frood R, Karthik S, Mirsadraee S, Clifton I, Flood K, McPherson SJ. Bronchial artery embolisation for massive haemoptysis: immediate and long-term outcomes-a retrospective study. Pulm Ther. 2020;6:107–17. https://doi.org/10.1007/s41030-020-00112-x.
Chen J, Chen L-A, Liang Z-X, Li C-S, Tian Q, Yang Z, et al. Immediate and long-term results of bronchial artery embolization for hemoptysis due to benign versus malignant pulmonary diseases. Am J Med Sci. 2014;348:204–9. https://doi.org/10.1097/MAJ.0000000000000226.
Wang GR, Ensor JE, Gupta S, Hicks ME, Tam AL. Bronchial artery embolization for the management of hemoptysis in oncology patients: utility and prognostic factors. J Vasc Interv Radiol. 2009;20:722–9. https://doi.org/10.1016/j.jvir.2009.02.016.
Hu P, Wang G, Cao H, Ma H, Sui P, Du J. Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection. Br J Cancer. 2013;109:1609–17. https://doi.org/10.1038/bjc.2013.485.
Han K, Yoon KW, Kim JH, Kim GM. Bronchial artery embolization for hemoptysis in primary lung cancer: a retrospective review of 84 patients. J Vasc Interv Radiol. 2019;30:428–34. https://doi.org/10.1016/j.jvir.2018.08.022.
Garcia-Olivé I, Sanz-Santos J, Centeno C, Andreo F, Muñoz-Ferrer A, Serra P, et al. Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm. J Vasc Interv Radiol. 2014;25:221–8. https://doi.org/10.1016/j.jvir.2013.09.017.
Fujita T, Tanabe M, Moritani K, Matsunaga N, Matsumoto T. Immediate and late outcomes of bronchial and systemic artery embolization for palliative treatment of patients with nonsmall-cell lung cancer having hemoptysis. Am J Hosp Palliat Care. 2014;31:602–7. https://doi.org/10.1177/1049909113499442.
Park HS, Kim YI, Kim HY, Zo J-I, Lee JH, Lee JS. Bronchial artery and systemic artery embolization in the management of primary lung cancer patients with hemoptysis. Cardiovasc Intervent Radiol. 2007;30:638–43. https://doi.org/10.1007/s00270-007-9034-5.
Marcelin C, Soussan J, Desmots F, Gaubert J-Y, Vidal V, Bartoli JM, et al. Outcomes of pulmonary artery embolization and stent graft placement for the treatment of hemoptysis caused by lung tumors. J Vasc Interv Radiol. 2018;29:975–80. https://doi.org/10.1016/j.jvir.2018.01.773.
Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51. https://doi.org/10.1016/j.jtho.2015.09.009.
Marquis KM, Raptis CA, Rajput MZ, Steinbrecher KL, Henry TS, Rossi SE, et al. CT for evaluation of hemoptysis. Radiographics. 2021;41:742–61. https://doi.org/10.1148/rg.2021200150.
Kettenbach J, Ittrich H, Gaubert JY, Gebauer B, Vos JA. CIRSE standards of practice on bronchial artery embolisation. Cardiovasc Interv Radiol. 2022;45:721–32. https://doi.org/10.1007/s00270-022-03127-w.
Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Interv Radiol. 2017;40:1141–6. https://doi.org/10.1007/s00270-017-1703-4.
Panda A, Bhalla AS, Goyal A. Bronchial artery embolization in hemoptysis: a systematic review. Diagn Interv Radiol. 2017;23:307–17. https://doi.org/10.5152/dir.2017.16454.
Befera NT, Ronald J, Kim CY, Smith TP. Spinal arterial blood supply does not arise from the bronchial arteries: a detailed analysis of angiographic studies performed for hemoptysis. J Vasc Interv Radiol. 2019;30:1736–42. https://doi.org/10.1016/j.jvir.2019.07.033.
Gailloud P. Spinal vascular anatomy. Neuroimaging Clin N Am. 2019;29:615–33. https://doi.org/10.1016/j.nic.2019.07.007.
Zhang Q, Li J, He G, Tang J, Zhang G. Utility of intra-procedural cone-beam computed tomography imaging for the determination of the artery of Adamkiewicz suspected by angiography during transarterial embolization for hemoptysis. Diagn Interv Radiol. 2023. https://doi.org/10.4274/dir.2022.221646.
Razazi K, Parrot A, Khalil A, Djibre M, Gounant V, Assouad J, et al. Severe haemoptysis in patients with nonsmall cell lung carcinoma. Eur Respir J. 2015;45:756–64. https://doi.org/10.1183/09031936.00010114.
Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, et al. Survival patterns in lung and pleural cancer in Europe 1999–2007: results from the EUROCARE-5 study. Eur J Cancer. 2015;51:2242–53. https://doi.org/10.1016/j.ejca.2015.07.033.
Funding
This study was not supported by any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
This study was approved by our Institutional Review Board.
Human or Animal Participants
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
Informed Consent
For this type of study informed consent is not required.
Consent for Publication
For this type of study consent for publication is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Le Tat, T., Carlier, R., Zhang, N. et al. Endovascular Management of Life-Threatening Hemoptysis in Primary Lung Cancer: A Retrospective Study. Cardiovasc Intervent Radiol 46, 891–900 (2023). https://doi.org/10.1007/s00270-023-03488-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-023-03488-w